A primary hepatocellular carcinoma case
Conditions
Interventions
Preoperative transarterial chemoembolization of whole liver for hepatocellular carcinoma
Preoperative transarterial chemoembolization of the selective liver for hepatocelullar carcinoma
No preoperativ
Sponsors
Departement of Surgery, Kansai Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)no preceded treatment 2)no extrahepatic lesion or major vascular invasion 3)performance status 0-2 4) bone marrow function and hepatic/renal functions are well maintained a)White blood cell count: 2000- 10000/mm3 b)Platelet count of 50000/mm3 or more c)Hemoglobin of 8.0g/dL or more d)Serum total bilirubin of 2.0mg/dL or less e)Prothronbin time of 50% or more f)Serum creatinine of 1.5mg/dL or less g)Blood urea nitrogen of 35mg/dL or less
Exclusion criteria
Exclusion criteria: 1) Double cancer or history of other malignancy within 5 years after diagnosis 2) History of myocardial infarction or unstable angina within 6 months prior to registration 3) Patient with interstitial pneumonia, pneumofibrosis, or severe lung emphysema 4) Patient who cannot undergo enhanced CT scan due to some reason such as allergy for iodized contrast media or renal dysfunction 5) Patient with psychiatric disorder or symptom 6) Pregnant patient or patient with possibility to be pregnant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival Recurrence-free survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Preoperative liver function Types of recurrence Therapeutic choice for primary recurrence | — |
Countries
Japan
Contacts
Public ContactMasaki Kaibori
Kansai Medical University Surgery
Outcome results
None listed